FIREFLEYE
Firefleye is an IT company that offers application, data, and project development services.
FIREFLEYE
Industry:
Information Technology Software Web Apps
Founded:
2015-01-01
Address:
Kraainem, Vlaams-Brabant, Belgium
Country:
Belgium
Website Url:
http://www.firefleye.be
Total Employee:
1+
Status:
Active
Contact:
32 478 78 31 80
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Fabres
Fabres is an IT company that offers software development services.
ITShastra
ITShastra is an IT consultancy company that provides application, web design, and custom product development services.
Sopamo
Sopamo is an IT company that offers sustainable web applications, databases and software services.
Official Site Inspections
http://www.firefleye.be
- Host name: webcluster1.webpod16-cph3.one.com
- IP address: 46.30.215.82
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "Firefleye"
Firefleye
Search this website. Home; Services. Application Development; Data Development; HomeSee details»
About - Firefleye
Firefleye is a team of passionate people who aim to deliver solid solutions in the vast space of IT. Once upon a time we were young and wild but time has changed us into reliable, caring …See details»
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of ...
Apr 1, 2024 Importance: Prospective long-term data after retinopathy of prematurity (ROP) treatment with anti-vascular endothelial growth factor injections vs laser therapy are scarce. …See details»
Aflibercept to treat retinopathy of prematurity: need for more …
May 10, 2024 The FIREFLEYE (Aflibercept for ROP-IVT injection versus Laser Therapy) was a noninferiority, phase III, 24-week, open-label randomized clinical trial to evaluate whether …See details»
Efficacy and safety of intravitreal aflibercept compared with laser ...
The aim of the FIREFLEYE study was to compare the efficacy and safety of IVT-AFL injections with laser photocoagulation for patients with ROP. Setting/Venue FIREFLEYE (NCT04004208) …See details»
FDA approves EYLEA for treatment of retinopathy of …
Feb 9, 2023 Comparing EYLEA to laser, ocular adverse events (AEs) among patients occurred in 39% versus 37% in FIREFLEYE and 18% versus 26% in BUTTERFLEYE. Serious ocular AEs occurred in 8% for both groups in …See details»
Aflibercept and Eylea (Aflibercept, BAY86-5321) and Laser ... - ICH …
Jun 28, 2019 Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial. JAMA. 2022 Jul …See details»
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on ...
Jul 7, 2022 The FIREFLEYE (Aflibercept for ROP—IVT Injection versus Laser Therapy) trial aimed to evaluate whether a 0.4-mg dose of intravitreal aflibercept was noninferior to laser …See details»
Ophthalmic VEGF inhibitor Eylea Solution for Intravitreal Injection …
Sep 26, 2022 The application for approval was based on the results of the FIREFLEYE study, a global phase 3 study investigating the efficacy and safety of ®Eylea administered intravitreally …See details»
Two-year outcomes from FIREFLEYE Next, a prospective follow-up …
The ongoing FIREFLEYE Next study is sponsored by Bayer AG (Leverkusen, Germany).The sponsor participated in the design and conduct of the study, analysis of the data, and …See details»
At 2 Years, Anti-VEGF Treatment, Laser Equal for ROP: …
Nov 15, 2023 The FIREFLEYE Next trial treated 66 children with 0.4 mg of intravitreal aflibercept and 34 with laser photocoagulation. Aflibercept (Eylea), an anti-vascular endothelial growth factor ...See details»
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on ...
Jul 26, 2022 Importance: Laser photocoagulation, which is the standard treatment for retinopathy of prematurity (ROP), can have adverse events. Studies of anti-vascular …See details»
Anti-VEGF Therapy for Retinopathy of Prematurity
Oct 1, 2024 In 2022, the FIREFLEYE clinical trial assessed if aflibercept 0.4 mg monotherapy was noninferior to the standard laser therapy in infants with severe ROP. 16 Treatment …See details»
Systemic exposure to aflibercept after intravitreal injection in ...
Jan 10, 2024 FIREFLEYE (NCT04004208) was a 24-week, randomized, open-label, noninferiority trial assessing the efficacy and safety of aflibercept versus laser …See details»
Aflibercept Matches Laser for Retinopathy of Prematurity
Sep 21, 2021 Stahl presented the findings of the FIREFLEYE trial at the European Society of Retina Specialists (EURETINA) 2021 meeting. "It is the first randomized, controlled study on …See details»
Intravitreal aflibercept compared with laser photocoagulation for ...
Purpose : FIREFLEYE was the first randomized, controlled, multicenter, international Phase 3 trial of patients with treatment requiring retinopathy of prematurity (ROP) that compared the …See details»
Efficacy and safety outcomes from the FIREFLEYE next study of …
APost-hoc analysis. A child was considered as having ROP recurrence if: the inclusion criteria of FIREFLEYE (or worse) were reported and a previous assessment (either in FIREFLEYE or in …See details»
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of ...
Apr 30, 2024 The FIREFLEYE next study will follow up children in Asia, Europe, and South America through 5 years of age after treatment of severe acute-phase ROP in the FIREFLEYE …See details»
Aflibercept for ROP Shows Sustained Efficacy at Age 3 - Medscape
Oct 2, 2024 A total of 113 children were enrolled in the original FIREFLEYE trial, 100 continued on to FIREFLEYE next, and 90 completed a visit at age 3. Primary outcomes included the …See details»